SWOG clinical trial number
SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)

A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer

Closed
Phase
Published
Abbreviated Title
A Phase III Study of Cisplatin plus Etoposide Combined with Standard Fractionation Thoracic Radiotherapy vs Cisplatin plus Etoposide Combined with Multiple Daily Fractionated Thoracic Radiotherapy…
Activated
02/15/1990
Closed
08/01/1992

Research committees

Lung Cancer

Other Clinical Trials

S2414
SWOG Clinical Trial Number
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
1% Accrual
Accrual
1%
Open
Phase
CTSU/NRG-LU007
SWOG Clinical Trial Number